Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-24-006401
Filing Date
2024-11-12
Accepted
2024-11-12 09:32:11
Documents
2

Document Format Files

Seq Description Document Type Size
1 HERON THERAPEUTICS, INC. p24-3088sc13g.htm SC 13G 70557
2 JOINT FILING AGREEMENT PURSUANT TO RULE 13D-1(K) p24-3088exhibit99.htm EX-99.1 3389
  Complete submission text file 0000902664-24-006401.txt   75719
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Subject) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-39444 | Film No.: 241444204
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116 617-867-2800
Adage Capital Management, L.P. (Filed by) CIK: 0001535978 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G